Journal of Osteoporosis / 2011 / Article / Tab 2

Clinical Study

Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy

Table 2

BMD and FRAX stratified by presence of vertebral fracture.

No vertebral fracture Vertebral fracture
n = 56n = 22

BMD, femoral neck0.––0.90.34
T score, femoral neck−1.8−1.90.7−3.3–−0.7−2.2−2.00.8−3.4–−0.60.33
BMD, total hip0.––1.20.22
T score, total hip−1.2−1.30.9−3.0–0.3−1.4−1.51.1−3.7–0.00.51
BMD, lumbar spine1.––1.30.11
T score, lumbar spine−1.1−0.91.6−4.0–4.6−1.8−1.61.8−5.2–2.10.10
FRAX (Osteo) without BMD (%)9.310.86.21.8––31.00.001
FRAX (Hip) without BMD (%)––25.00.03
FRAX (Osteo) with BMD (%)––41.00.002
FRAX (Hip) with BMD (%)––36.00.03

* P values are from the Wilcoxon rank sum test.
BMD measurements are in g/cm2.